{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:27:57Z","timestamp":1777444077496,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Complementary Therapies in Clinical Practice"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ctcp.2012.02.002","type":"journal-article","created":{"date-parts":[[2012,3,31]],"date-time":"2012-03-31T00:15:55Z","timestamp":1333152955000},"page":"190-194","source":"Crossref","is-referenced-by-count":22,"title":["Effect of a combined nutraceutical containing Orthosiphon stamineus effect on blood pressure and metabolic syndrome components in hypertensive dyslipidaemic patients: A randomized clinical trial"],"prefix":"10.1016","volume":"18","author":[{"given":"A.F.G.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"De Sando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Trimarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctcp.2012.02.002_bib1","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.ctcp.2012.02.002_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1751-7176.2009.00207.x","volume":"11","author":"Bloch","year":"2009","journal-title":"J\u00a0Clin Hypertens"},{"issue":"1","key":"10.1016\/j.ctcp.2012.02.002_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1753944707087409","article-title":"The New European Society of Hypertension\/European Society of Cardiology (ESH\/ESC) Guidelines","volume":"2","author":"Mancia","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"4","key":"10.1016\/j.ctcp.2012.02.002_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007187.pub2","article-title":"Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertension","author":"Chen","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ctcp.2012.02.002_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1751-7176.2009.00138.x","article-title":"Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy","volume":"11","author":"Elliott","year":"2009","journal-title":"J\u00a0Clin Hypertens"},{"issue":"Suppl.","key":"10.1016\/j.ctcp.2012.02.002_bib6","first-page":"23","article-title":"Hyperlipidemia of diuretic therapy","volume":"91","author":"Ames","year":"1998","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"4","key":"10.1016\/j.ctcp.2012.02.002_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1755-5922.2010.00165.x","article-title":"Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function","volume":"28","author":"Zuchi","year":"2010","journal-title":"Cardiovasc Ther"},{"issue":"7","key":"10.1016\/j.ctcp.2012.02.002_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/jhh.2010.85","article-title":"Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysisof current available clinical trials","volume":"25","author":"Cicero","year":"2011","journal-title":"J Hum Hyper"},{"issue":"6","key":"10.1016\/j.ctcp.2012.02.002_bib9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/erc.10.63","article-title":"Nutrition and nutraceutical supplements in the treatment of hypertension","volume":"8","author":"Houston","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"10.1016\/j.ctcp.2012.02.002_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jep.2009.04.014","article-title":"Diuretic properties of Orthosiphon stamineus Benth","volume":"124","author":"Adam","year":"2009","journal-title":"J\u00a0Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.ctcp.2012.02.002_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0028-1088379","article-title":"Adenosine A1 receptor binding activity of methoxy flavonoids from Orthosiphon stamineus","volume":"75","author":"Yuliana","year":"2009","journal-title":"Planta Med"},{"issue":"4","key":"10.1016\/j.ctcp.2012.02.002_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ecam\/nem141","article-title":"Orthosiphon versus placebo in nephrolithiasis with multiple chronic complaints: a randomized control trial","volume":"6","author":"Premgamone","year":"2009","journal-title":"Evid Based Complement Alternat Med"},{"issue":"Suppl. 2","key":"10.1016\/j.ctcp.2012.02.002_bib13","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","volume":"14","author":"Graham","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"3\u20134","key":"10.1016\/j.ctcp.2012.02.002_bib14","first-page":"121","article-title":"Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome","volume":"7","author":"Cicero","year":"2009","journal-title":"Curr Top Nutrac Res"},{"key":"10.1016\/j.ctcp.2012.02.002_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","volume":"25","author":"Mancia","year":"2007","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.ctcp.2012.02.002_bib16","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ctcp.2012.02.002_bib17","first-page":"393","article-title":"Evaluation of the global cardiovascular absolute\u00a0risk: the Progetto CUORE individual score","volume":"40","author":"Palmieri","year":"2004","journal-title":"Ann Ist Super Sanita"},{"issue":"Suppl. 2","key":"10.1016\/j.ctcp.2012.02.002_bib18","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ijo.2008.29","article-title":"Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study","volume":"32","author":"Assmann","year":"2008","journal-title":"Int J Obes"},{"issue":"6","key":"10.1016\/j.ctcp.2012.02.002_bib19","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/HJR.0b013e32833158e4","article-title":"Effect of\u00a0a sequential training program on inflammatory, prothrombotic and vascular\u00a0remodelling biomarkers in hypertensive overweight patients with or\u00a0without metabolic syndrome","volume":"16","author":"Cicero","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehab"},{"issue":"9","key":"10.1016\/j.ctcp.2012.02.002_bib20","first-page":"1097","article-title":"Diet and exercise in the management of hyperlipidemia","volume":"81","author":"Kelly","year":"2010","journal-title":"Am Fam Physician"},{"issue":"12","key":"10.1016\/j.ctcp.2012.02.002_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archinternmed.2010.182","article-title":"Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants","volume":"170","author":"Ray","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.ctcp.2012.02.002_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ypmed.2009.05.003","article-title":"Complementary\/alternative medicine in the context of prevention of disease and maintenance of health","volume":"49","author":"Kraft","year":"2009","journal-title":"Prev Med"},{"issue":"9","key":"10.1016\/j.ctcp.2012.02.002_bib23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/14786410903417378","article-title":"Cardiovascular friendly natural products: a promising approach in the management of CVD","volume":"24","author":"Shukla","year":"2010","journal-title":"Nat Prod Res"},{"issue":"11","key":"10.1016\/j.ctcp.2012.02.002_bib24","first-page":"1529","article-title":"Complementary and alternative medicine approaches to blood pressure reduction: an evidence-based review","volume":"54","author":"Nahas","year":"2008","journal-title":"Can Fam Physician"},{"issue":"4","key":"10.1016\/j.ctcp.2012.02.002_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2010.07.001","article-title":"Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review","volume":"4","author":"Nijjar","year":"2010","journal-title":"J\u00a0Clin Lipidol"},{"issue":"9","key":"10.1016\/j.ctcp.2012.02.002_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","article-title":"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study","volume":"20","author":"Affuso","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.ctcp.2012.02.002_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1742-1241.2009.02263.x","article-title":"The association between serum uric acid level and coronary artery disease","volume":"64","author":"Sinan Deveci","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"2","key":"10.1016\/j.ctcp.2012.02.002_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12349-008-0011-6","article-title":"Natural sources of antidyslipidaemic agents: is there an evidence-based approach for their prescription?","volume":"1","author":"Cicero","year":"2008","journal-title":"Med J Nutr Metab"},{"issue":"7","key":"10.1016\/j.ctcp.2012.02.002_bib29","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/HJH.0b013e3283395208","article-title":"Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia","volume":"28","author":"Izzo","year":"2010","journal-title":"J\u00a0Hypertens"},{"issue":"6","key":"10.1016\/j.ctcp.2012.02.002_bib30","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/erc.10.59","article-title":"Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects?","volume":"8","author":"Correa","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ctcp.2012.02.002_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/924851","article-title":"Berberine moderates glucose and lipid metabolism through multipathway mechanism","author":"Zhang","year":"2011","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.ctcp.2012.02.002_bib32","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.hjh.0000220402.53869.72","article-title":"Pathophysiological regulation of the AT1-receptor and implications for vascular disease","volume":"24","author":"Wassmann","year":"2006","journal-title":"J\u00a0Hypertens Suppl"}],"container-title":["Complementary Therapies in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388112000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1744388112000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T13:25:34Z","timestamp":1543065934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1744388112000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1744388112000084"],"URL":"https:\/\/doi.org\/10.1016\/j.ctcp.2012.02.002","relation":{},"ISSN":["1744-3881"],"issn-type":[{"value":"1744-3881","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}